Fundamental Analysis
78 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +5058.4% | +1920.6% | 2 / 3 | +58.8% | -11.92 pp | -1.39 pp | +21.1% | 0.05 | 3.78 | 156 | +58,8% | 6,4 | +18,8% | 3.78 | 6.37 | −40,7% |
| Pts | 12 | 12 | 8 | 12 | 0 | 4 | 12 | 12 | 12 | |||||||
Valuation annotation:Price: 10.300 (close price on 2026-10-19)EPS (TTM): 2.725
Financial charts
1.Revenue & growth
VND bn156Q2/26
1.Revenue & growth
VND bn156Q2/26
2.Profit & growth
VND bn0,18Q2/26
3.Profit mix (Penman)
VND bn119Q2/26
4.Margins & cost structure
%29.2%Q2/26
5.Returns & cash cycle
% · days10.2%Q2/26
6.Earnings quality & cash
VND bn170Q2/26
7.Asset structure
VND bn615Q2/26
8.Funding & debt health
VND bn · times615Q2/26
9.Revenue backlog
VND bn90,6Q2/26
10.Valuation
times · %4,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %7Q2/26
Adjusted EPS growth, latest quarter
51,6× higher
Average adjusted EPS growth, 3 quarters
20,2× higher
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
-0.0%
Source: vnstockData through Q2/26